The Asia Pacific antibody uncovering market is witnessing robust expansion, fueled by a growing prevalence of chronic conditions and a heightened focus on personalized medicine. Notable investment in research and innovation, particularly within regions like China, Japan, and South Korea, is accelerating the adoption of advanced antibody identificat